Actively Recruiting
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
Led by M.D. Anderson Cancer Center · Updated on 2026-02-13
2000
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are collecting detailed information on female patients with low-grade ovarian or peritoneal tumors to build a comprehensive database. This study aims to gather both past and current data on the disease, treatments received, and patient outcomes to better understand these tumor types. The goal is to support future research and help develop improved treatments by analyzing patient and disease characteristics in relation to outcomes. The study involves reviewing patients' medical records retrospectively and prospectively to collect relevant clinical information. Additionally, leftover tissue samples from tumors may be collected and stored to create a tumor bank. The data and samples are securely stored in a single repository designed to facilitate research and maintain patient privacy. Participants contribute by allowing access to their medical records and, if available, providing residual tumor tissues for storage. Researchers will organize and analyze this clinical and biological data over a period of up to 28 years. The study focuses on securely archiving information to support ongoing and future research efforts, without requiring participants to undergo additional treatments or interventions.
CONDITIONS
Brief Title
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients with disease progression to a higher-grade carcinoma since original diagnosis
- Diagnosis includes ovarian tumor of low malignant potential
- Diagnosis includes low-grade serous carcinoma of the ovary
- Diagnosis includes primary peritoneal tumor of low malignant potential
- Diagnosis includes low-grade serous carcinoma of the peritoneum
- Diagnosis includes psammocarcinoma
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - Up to 28 years
Participants’ medical records are reviewed retrospectively and prospectively to collect data on disease characterization, treatment, and outcomes.
Data collection occurs through review of medical records without additional visits
Duration - Up to 28 years
Residual tissue samples may be collected and stored to establish a tumor bank.
1 to 2 visits depending on availability of tissue samples
Trial Site Locations
Total: 1 location
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
L
Lisa Nathan
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here